180 Life Sciences: Positive Data From Dupuytren’s Disease Study Could Be a Big Catalyst, Says Analyst
Yahoo! Finance
Over the past week, 180 Life Sciences (ATNF) stock has been on the rise, accumulating share gains of 40%. So, what’s behind the uptick? Well, ATNF does have meme stock credentials having been a retailers’ favorite this year, and we’ve all witnessed the power of the crowd’s ability to send stocks with a heavy short interest to improbable heights, although at 4.5% of the float, the short interest is not very high right now. That said, ATNF shares climbed higher perhaps in anticipation of a keynote
Continue Reading